Optimizing the Differentiation of iPSC Therapies to Enable Large-Scale Manufacturing & Clinical Applications
Time: 10:30 am
day: Conference Day One
Details:
- Investigating the mechanisms by which differentiated Cytovia’s iNK cells exert their anti-tumor effects
- Demonstrating the complete maturation and potent anti-tumor activity of differentiated iNK cells for optimal efficacy
